← Latest news 
Sun Pharma to acquire Organon for 12 5 billion its biggest deal yet
Business
Published on 26 April 2026
Paying for equity while inheriting massive debt
Sun Pharma is set to buy US drugmaker Organon for $12.5 billion, expected to be decided at a board meeting over the weekend. The Mumbai-based company will beat the EQT-Gruenthal consortium, paying $4.5 billion for Organon’s equity while taking on $8.5 billion of debt, with an announcement likely tonight or by Monday.
- Sun Pharma’s board meeting will finalize the Organon acquisition this weekend
- Deal value totals $12.5 billion, Sun’s biggest to date
- Sun pays $4.5 billion for equity and inherits $8.5 billion debt
- Consortium EQT-Gruenthal is reportedly outbid
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times